Oncology Department

The Department of Oncology was established in March 2000, with 100 open beds, divided into three ABC disease zones. It is mainly dedicated to the diagnosis and treatment of all types of malignant tumors (lung cancer, breast cancer, esophageal cancer, stomach cancer, colorectal cancer, hepatocellular pancreatitis, gynecologic cancer, urinary system tumor, head cancer, melanoma, soft tissue cancer, etc.), specifically implementing new assistive chemotherapy, postoperative chemotherapy, late-stage oncology, molecular therapy, immunotherapy, cancer pain, and hypoplastic therapy. Daytime chemotherapy and so on. The treatment of acute and post-tumor reactions is unique in that it focuses on the patient's TNM phase and overall process, norms, systematic management, promotes accurate treatment of malignant tumors through the implementation of a multidisciplinary MDT model and new drug clinical research to promote comprehensive accuracy, maximize survival of tumor patients, improve quality of life, enhance clinical experience. Team introduction: The faculty is made up of 63 physicians, 20 of whom are directors, 6 of whom are doctors, 7 are assistant doctors, 7 are doctoral students, 3 are PhD students, 10 are masters, 9 are postgraduate professors.